Literature DB >> 20541680

Melanoma epidemic: Facts and controversies.

Corinne Erickson1, Marcia S Driscoll.   

Abstract

The presence of a true melanoma epidemic has been a controversial topic for the past decade. A dramatic increase in the incidence of cutaneous malignant melanoma in developed countries is well documented, but mortality rates have not risen as rapidly. This has generated much discussion about whether there is a true increase in disease, or more of an apparent phenomenon that may be explained by multiple biases and other factors. The increase in incidence may be due to aggressive surveillance with increased detection of melanomas that are histologically worrisome but biologically benign. This argument, however, does not account for increased incidence of both thin and thicker melanomas. The controversy lies in the interpretation of these facts. This contribution reviews epidemiologic studies from the United States and worldwide to summarize the arguments for and against the debate about whether a melanoma epidemic exists. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20541680     DOI: 10.1016/j.clindermatol.2009.06.021

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  11 in total

1.  Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

Authors:  Erin X Wei; Abrar A Qureshi; Jiali Han; Tricia Y Li; Eunyoung Cho; Jennifer Y Lin; Wen-Qing Li
Journal:  J Am Acad Dermatol       Date:  2016-07-16       Impact factor: 11.527

Review 2.  A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.

Authors:  M Dietel; K Jöhrens; M V Laffert; M Hummel; H Bläker; B M Pfitzner; A Lehmann; C Denkert; S Darb-Esfahani; D Lenze; F L Heppner; A Koch; C Sers; F Klauschen; I Anagnostopoulos
Journal:  Cancer Gene Ther       Date:  2015-09-11       Impact factor: 5.987

3.  CDH22 expression is reduced in metastatic melanoma.

Authors:  Brad Piche; Shahram Khosravi; Magdalena Martinka; Vincent Ho; Gang Li
Journal:  Am J Cancer Res       Date:  2010-12-10       Impact factor: 6.166

Review 4.  Malignant melanoma: epidemiologic aspects, diagnostic and therapeutic approach.

Authors:  Michael Tronnier; Kristina Semkova; Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2013-05-29

Review 5.  Adoptive immunotherapy of advanced melanoma.

Authors:  Ronnie Shapira-Frommer; Jacob Schachter
Journal:  Curr Treat Options Oncol       Date:  2012-09

6.  Conditional random fields and supervised learning in automated skin lesion diagnosis.

Authors:  Paul Wighton; Tim K Lee; Greg Mori; Harvey Lui; David I McLean; M Stella Atkins
Journal:  Int J Biomed Imaging       Date:  2011-10-20

7.  Incidence and mortality trends of melanoma in Croatia.

Authors:  Jelena Barbarić; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

Review 8.  Treating advanced melanoma: current insights and opportunities.

Authors:  Michael Tronnier; Christina Mitteldorf
Journal:  Cancer Manag Res       Date:  2014-09-10       Impact factor: 3.989

9.  Delay in cutaneous melanoma diagnosis: Sequence analyses from suspicion to diagnosis in 211 patients.

Authors:  Marcus H S B Xavier; Ana P Drummond-Lage; Cyntia Baeta; Lorena Rocha; Alessandra M Almeida; Alberto J A Wainstein
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Epidemiological trends in skin cancer.

Authors:  Zoe Apalla; Aimilios Lallas; Elena Sotiriou; Elizabeth Lazaridou; Demetrios Ioannides
Journal:  Dermatol Pract Concept       Date:  2017-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.